Table 2 of Wang, Mol Vis 2012; 18:2578-2585.
Characteristic | Good responders (n=77) | Poor responders (n=29) |
---|---|---|
Mean age | 80.8±6.75 | 75.7±8.49 |
Mean age diagnosed with AMD | 77.4±8.40 | 71.8±8.86 |
Mean baseline BCVA in ETDRS letters (Snellen conversion) | 47.0±31.9 (20/250±6.4 lines) | 53.0±30.2 (20/160±6.0 lines) |
Change in visual acuity over 12 months (letters) | 2.1±15.1 | −2.0±12.7 |
Number of injections over 12 months | 4.8±3.1 | 5.9±2.81 |
Previous anti-VEGF therapy (%) | 19 (25%) | 3 (10%) |
% Male | 42% | 52% |
Ever Smoker | 58% | 48% |
Cardiovascular disease | 38% | 41% |
Diabetes | 14% | 12% |